Thus, VEGF inhibition through TKIs or VEGFR-directed monoclonal antibodies might increase local antitumor immunity and favorably modify the immunosuppressive tumor microenvironment, thus enhancing the effects of ICIs [45]. This evidence concerns the gene VEGFA and neoplasm.